Bernengo M, Vanaclocha F, Duvic M, Kuzel T, Kerdel F, Pinter-Brown L, Bosly A, Okada C, Breneman D, Zinzani P, Becker J, Hughey L, Ardaiz M, Zain J, Zhang L. A Phase II international, multicenter study of oral panobinostat (LBH589) in patients with refractory cutaneous T-cell lymphoma. Hematol Meeting Rep [Internet]. 2009 Jun. 23 [cited 2024 Nov. 22];2(5). Available from: https://www.pagepress.org/journals/hmr/article/view/725